A review of a bi-layered living cell treatment (Apligraf ^®) in the treatment of venous leg ulcers and diabetic foot ulcers

References

• BantaMNKirsnerRS2002Modulating diseased skin with tissue engineering: actinic purpura treated with ApligrafDermatol Surg281103612472487
   PubMed Web of Science ®Google Scholar
• BremHBalleduxJBloomT2000Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healingArch Surg1356273410843357
   PubMed Web of Science ®Google Scholar
• BremHKirsnerRSFalangaV2004Protocol for the successful treatment of venous ulcersAm J Surg1881815223495
   PubMed Web of Science ®Google Scholar
• BriscoeDMDharnidharkaVRIsaacsC1999The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejectionTransplantaton6715909
   PubMed Web of Science ®Google Scholar
• CavorsiJVicariFWirthlinDJ2006Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcersWound Repair Regen14102916630097
   PubMed Web of Science ®Google Scholar
• CulicanSMCusterPL2002Repair of cicatricial ectropion in an infant with harlequin ichthyosis using engineered human skinAm J Ophthalmol134442312208260
   PubMed Web of Science ®Google Scholar
• CurranMPPloskerGL2002Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcersBioDrugs164395512463767
   PubMed Web of Science ®Google Scholar
• DavisSCMartinezLKirsnerR2006The diabetic foot: the importance of biofilms and wound bed preparationCurr Diab Rep64394517118226
   PubMedGoogle Scholar
• DickinsonPJCarringtonALFrostGS2002Neurovascular disease, antioxidants and glycation in diabeticsDiabetes Metab Res Rev182607212203942
   PubMed Web of Science ®Google Scholar
• EaglsteinWHAlvarezOMAulettaM1999Acute excisional wounds treated with a tissue-engineered skin (Apligraf)Dermatol Surg2519520110193966
   PubMed Web of Science ®Google Scholar
• EaglsteinWHIriondoMLaszloK1995A composite skin substitute (Graftskin) for surgical wounds. A clinical experienceDermatol Surg21839437551738
   PubMed Web of Science ®Google Scholar
• FalabellaAFSchachnerLAValenciaIC1999The use of tissue-engineered skin (Apligraf) to treat a newborn with epidermolysis bullosaArch Dermatol3512192210522669
   PubMedGoogle Scholar
• FalabellaAFValenciaICEaglsteinWH2000Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa woundsArch Dermatol13612253011030768
   PubMed Web of Science ®Google Scholar
• FalangaVJ2000Tissue engineering in wound repairAdv Skin Wound Care,13151911074998
   PubMedGoogle Scholar
• FalangaVIsaacsCPaquetteD2002Wounding of bioengineered skin: cellular and molecular aspects after injuryJ Invest Dermatol1196536012230509
   PubMed Web of Science ®Google Scholar
• FalangaVMargolisDAlvarezO1998Rapid healing of veous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators GroupArch Dermatol1342933009521027
   PubMed Web of Science ®Google Scholar
• FivensonDScherschunL2003Clinical and economic impact of Apligraf for the treatment of nonhealing venous leg ulcersInt J Dermatol42960514636194
   PubMed Web of Science ®Google Scholar
• FloresFEaglsteinWAKirsnerRS2000Hydroxyurea-induced leg ulcers treated with ApligrafAnn Intern Med1324171810691597
   PubMed Web of Science ®Google Scholar
• GohariSGamblaCHealeyM2002Evaluation of tissue-engineered skin (human skin substitute) and secondary intention healing in the treatment of full thickness wounds after Mohs micrographic or excisional surgeryDermatol Surg2811071412472488
   PubMed Web of Science ®Google Scholar
• GoodridgeDTrepmanESloanJ2006Quality of life of adults with unhealed and healed diabetic foot ulcersFoot Ankle Int272748016624217
   PubMed Web of Science ®Google Scholar
• HardingKCuttingKPriceP2000The cost-effectiveness of wound management protocols of careBr J Nurs9S6S8S10passim12271239
   PubMedGoogle Scholar
• HayesDWJrWebbGEMandracchiaVJ2001Full-thickness burn of the foot: successful treatment with Apligraf. A case reportClin Podiatr Med Surg181798811344977
   PubMedGoogle Scholar
• HessCTKirsnerRS2003Orchestrating wound healing: assessing and preparing the wound bedAdv Skin Wound Care162465714581817
   PubMedGoogle Scholar
• HuSKirsnerRSPhillipsT2006Evaluation of Apligraf ® persistence and basement membrane restoration in donor site wounds: a pilot studyWound Repair Regen144273316939570
   PubMed Web of Science ®Google Scholar
• MaierJPLippittCMooneyEK2002Use of tissue-engineered skin in the dermal atrophy patient with traumatic avulsion injuriesAnn Plast Surg49677212142598
   PubMed Web of Science ®Google Scholar
• MartinLKKirsnerRS2003Ulcers caused by bullous morphea treated with tissue-engineered skinInt J Dermatol42402412755984
   PubMed Web of Science ®Google Scholar
• MathiasSDPrebilLABoykoWL2000Health-related quality of life in venous leg ulcer patients successfully treated with Apligraf: a pilot studyAds Skin Wound Care13768
   Google Scholar
• MeerwaldtRLinksTPGraaffR2005Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathyDiabetologia4816374416021416
   PubMed Web of Science ®Google Scholar
• MuhartMMcFallsSKirsnerRS1999Behavior of tissue-engineered skin: a comparison of a living skin equivalent, autograft, and occlusive dressing in human donor sitesArch Dermatol1359131810456339
   PubMed Web of Science ®Google Scholar
• PhillipsTJManzoorJRojasA2002The longevity of a bilayered skin substitute after application to venous ulcersArch Dermatol13810798112164746
   PubMed Web of Science ®Google Scholar
• RedekopWKMcDonnellJVerboomP2003The cost effectiveness of Apligraf treatment of Diabetic foot ulcersPharmacoeconomics2111718314594438
   PubMed Web of Science ®Google Scholar
• SchonfeldWHVillaKFFastenauJM2000An economic assessment of Apligraf (Graftskin) for the treatment of hard-to-heal venous leg ulcersWound Repair Regen8251711013015
   PubMed Web of Science ®Google Scholar
• StreitMBohlenLMBraathenLR2001Ulcerative sarcoidosis successfully treated with ApligrafDermatology2023677011455163
   PubMed Web of Science ®Google Scholar
• StreitMBraathenLR2000Apligraf—a living human skin equivalent for the treatment of chronic woundsInt J Artif Organs23831311197742
   PubMed Web of Science ®Google Scholar
• TrentJTFalabellaAEaglsteinWH2005Venous ulcers: pathophysiology and treatment optionsOstomy Wound Manage513554
   Google Scholar
• VevesAFalangaVArmstrongDG2001Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trialDiabetes Care24290511213881
   PubMed Web of Science ®Google Scholar
• WaymackPDuffRGSabolinskiM2000The effect of a tissue engineered billayered living skin analog over meshed split-thickness autografts on the healing of excised burn wounds. The Apligraf Burn Study GroupBurns266091910925183
   PubMed Web of Science ®Google Scholar
• WuSArmstrongDG2005Risk assessment of the diabetic foot and woundInt Wound J2172416722851
   PubMedGoogle Scholar